Springer Nature
Browse
13395_2019_198_MOESM4_ESM.tif (510.98 kB)

Additional file 4: of Preclinical rationale for entinostat in embryonal rhabdomyosarcoma

Download (510.98 kB)
figure
posted on 2019-05-21, 05:00 authored by Narendra Bharathy, Noah Berlow, Eric Wang, Jinu Abraham, Teagan Settelmeyer, Jody Hooper, Matthew Svalina, Zia Bajwa, Martin Goros, Brian Hernandez, Johannes Wolff, Ranadip Pal, Angela Davies, Arya Ashok, Darnell Bushby, Maria Mancini, Christopher Noakes, Neal Goodwin, Peter Ordentlich, James Keck, Douglas Hawkins, Erin Rudzinski, Atiya Mansoor, Theodore Perkins, Christopher Vakoc, Joel Michalek, Charles Keller
Figure S4. siRNA-mediated knockdown of HDAC3 in eRMS and aRMS. Analysis of MHC expression in RD, Rh30 and HSMM cell lines transfected with siRNA at 100 nM for 72 h, targeting HDAC3. (TIF 510 kb)

Funding

National Institute of Health (US)

History

Usage metrics

    Skeletal Muscle

    Categories

    Keywords

    Embryonal rhabdomyosarcoma (eRMS)EntinostatVincristineHDAC3Patient-derived xenograft (PDX)

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC